Caliber Therapeutics
About:
Caliber Therapeutics offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs.
Website: http://www.calibertherapeutics.com
Top Investors: SternAegis
Description:
Caliber Therapeutics, Inc. engages in the development and commercialization of minimally-invasive balloon-based drug delivery products for the intervention of atherosclerotic diseases. It offers Targeted Angioplasty Drug Delivery balloon, a stent-free delivery platform of anti-restenotic drugs, which enables controlled and targeted drug delivery, reduces thrombosis risk, and reduces the need to implant permanent devices.
$12M
$1M to $10M
New Hope, Pennsylvania, United States
2005-01-01
Bill Baumbach, David Hochman
11-50
2017-06-13
Private
© 2025 bioDAO.ai